Ads
related to: bristol-myers squibb stock price today
Search results
Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know
Zacks via Yahoo Finance· 9 hours agoBristol Myers (BMY) has received quite a bit of attention from Zacks.com users lately. Therefore, it...
10 Health Care Stocks With Whale Alerts In Today's Session - Annovis Bio (NYSE:ANVS), Bristol-Myers ...
Benzinga· 1 day agoIt expires in 38 day(s) on June 21, 2024 . Parties traded 1790 contract(s) at a $40.00 strike. The total cost received by the writing party (or parties) was $930.8K , with a price< ...
Cytokinetics Reverses Higher On 'Pristine' Results For Bristol Myers-Rivaling Heart Drug
Investor's Business Daily· 1 day agoHe has a buy rating and 108 price target on Cytokinetics stock. Blum estimates just 5% of patients...
Down but Not Out: 3 Stocks to Buy on a Post-Earnings Dip
The Motley Fool via AOL· 4 days agoAt its recent market price of $44.74 per share, that means the company is available for around 6.5...
Bristol Myers (BMY) Fails to Meet Goal in Opdivo NSCLC Study
Zacks via Yahoo Finance· 2 days agoBristol Myers' (BMY) late-stage label-expanding study evaluating the Opdivo/Yervoy combination fails...
Prothena (PRTA) Q1 Earnings Miss Estimates on Higher R&D Expenses
Zacks via Yahoo Finance· 6 days agoNet loss for 2024 is expected in the band of $229-$255 million. PRTA currently carries a Zacks Rank...
How Neurocrine Is Stacking Up Wins In 2024 — And Outperforming Peers
Investor's Business Daily· 6 days agoHighly Rated Biotech Stock Today, Neurocrine stock has a strong Composite Rating of 97 out of a...
Bull of the Day: Veeva Systems (VEEV)
Zacks via Yahoo Finance· 3 days agoThe tech firm and the stock are proven winners. Now might be the time for investors to heed tried-and-true investment advice and buy Veeva while others...
European Midday Briefing: Traders Await Key U.S. Inflation Data This Week
Morningstar· 3 days agoEuropean shares traded lower on Monday as investors awaited U.S. inflation data later in the week. "Much hinges on the U.S. April inflation report, with a lower reading boosting odds of a Fed ...
Earnings call: Editas Medicine outlines strategic pillars for 2024
Investing.com· 7 days agoEditas Medicine (NASDAQ: EDIT ) has reported significant strides in its first quarter of 2024,...